Objective To study the efficacy and safety of CO2 laser microsurgery for early glottis carcinoma.Methods The data of 96 cases of early glottic laryngeal carcinoma treated with CO2 laser microsurgery were retrospectively analyzed.Surgical specimens were conventionally embedded with paraffin and serially sectioned.Sections were stained by using hematoxylin-eosin for pathologic examination.The local control rate was observed after operation.Results Among the 96 specimens,88 surgical margins were negative and 8 were positive.10 patients (10.4 ％) recurrenced followed up for 3 years.The recurrence rates of Tis,T1a,T1b and T2 were 0 (0/10),4.1％ (2/48),25.0 ％ (4/16) and 18.1％ (4/22),respectively,with significant differences among groups (X2 =6.105,P ＜ 0.05).All of 8 cases with positive margin and 2 cases with negative margin were recurrened.The recurrent rate of patients with involvement of the anterior commissure was 30.0 ％ (6/20),which was higher than that of patients with no tumor invasion [5.3 ％ (4/76)] (X2 =9.624,P ＜ 0.01).Conclusions The safe edges can be obtained by CO2 laser microsurgery for early stage of glottis carcinoma,which have advantages in local control rate,vocal function of the larynx and curative effect.

Since December 2019,the rapid spread of coronavirus disease 2019(COVID-19)poses a serious threat to global public health security.Obstructive sleep apnea hypopnea syndrome(OSAHS)is commonly occurred in patients with COVID-19,however,due to the lack of understand-ing of their comorbidities,the damage of OSAHS is often underestimated or even ignored.OSAHS has not been identified as an independent risk factor that increases the possibility of severe acute respirato-ry syndrome coronavirus 2(SARS-CoV-2)infection and aggravates the disease.In addition,the un-derstanding of traditional Chinese medicine for the prevention and treatment of novel coronavirus pneumonia complicated with OSAHS at home and abroad is not profound,and related studies are also few.The purpose of this article is to improve clinicians'knowledge and understanding of COVID-19 combined with OSAHS,which may provide some guidance in dealing with this disease.

Since December 2019,the rapid spread of coronavirus disease 2019(COVID-19)poses a serious threat to global public health security.Obstructive sleep apnea hypopnea syndrome(OSAHS)is commonly occurred in patients with COVID-19,however,due to the lack of understand-ing of their comorbidities,the damage of OSAHS is often underestimated or even ignored.OSAHS has not been identified as an independent risk factor that increases the possibility of severe acute respirato-ry syndrome coronavirus 2(SARS-CoV-2)infection and aggravates the disease.In addition,the un-derstanding of traditional Chinese medicine for the prevention and treatment of novel coronavirus pneumonia complicated with OSAHS at home and abroad is not profound,and related studies are also few.The purpose of this article is to improve clinicians'knowledge and understanding of COVID-19 combined with OSAHS,which may provide some guidance in dealing with this disease.

OBJECTIVE: Investigate the specific antitumor mechanism of SOCS1 silent DC vaccine and discuss the prospect of RNAi in the gene therapy for laryngocarcinoma in order to provide novel ideas of DCs clinical applications. METHOD: Dendritic cells derived from peripheral blood monocytes were cultured in vitro in the presence of GM-CSF, IL-4 and TNF-alpha. The morphological feature of DC was observed with inverted microscope. RNAi vector were transfected into DC. The expression of SOCS1 protein was detected with Western blot. The effective target sequences of siRNA against SOCS1 were screened out. The surface markers of mature DC, including CD83, CD86 and HLA-DR, were detected with flow cytometry. The concentration of IFN-gamma in the supernatant was assayed by ELISA. The proliferative ability of T cell stimulated by DC and the specific killing activity of cytotoxic T lymphocyte (CTL) induced by DC were evaluated by MTT assay. RESULT: Dendritic cells were obtained successfully. The RNAi vector was proved to be right by sequencing. The expression of SOCS1 decreased significantly under the influence of the 5th interference sequence. SOCS1 silent dendritic cells which were loaded with Hep-2 antigen had high expressions of CD83 (85.61 +/- 0.96)%, CD86 (96.86 +/- 1.20)% and HLA-DR (98.02 +/- 0.94)%. It could also stimulate the proliferation of T cells effectively as well as could increase the production of IFN-gamma, eventually enhanced the specific killing effect of CTL. The killing activity was more higher than that in control group when the effect cells and target cells were mixed up at the ratio of 50:1 (P < 0.01). CONCLUSION SOCS1 silent DC vaccines which were loaded with Hep-2 antigen could induce effective and specific anti-laryngocarcinoma immune responses.
Cancer Vaccines ; immunology ; Cell Line, Tumor ; Cells, Cultured ; Dendritic Cells ; drug effects ; immunology ; Gene Silencing ; Granulocyte-Macrophage Colony-Stimulating Factor ; pharmacology ; Humans ; Interleukin-4 ; pharmacology ; Laryngeal Neoplasms ; therapy ; RNA, Small Interfering ; Suppressor of Cytokine Signaling 1 Protein ; Suppressor of Cytokine Signaling Proteins ; genetics ; Tumor Necrosis Factor-alpha ; pharmacology

Objective To investigate the role of LncRNAs-MEG3 in the carcinogenesis and progression of nasopharyngeal carcinoma (NPC) and the possible molecular mechanism. Methods qRT-PCR was used to detect the content of MEG3 and miR-543 in NPC cells. Luciferase reporter method was used to study the relation between MEG3 and miR-543, and the changes of cell proliferation and apoptosis induced by MEG3 or KLF4 were analyzed. Western blot was used to detect the expression of KLF4, Bcl-2 and Bax proteins. Results Compared with the control group, the expression of miR-543 in NPC cell line was significantly increased (P < 0.05), while the expression of MEG3 was decreased (P < 0.05). Luciferase report and Western blot showed that MEG3 could regulate the expression of KLF4 by adsorbing miR-543 to inhibit cell proliferation, promote cell apoptosis and affect the expression levels of Bcl-2 and Bax proteins. Conclusion LncRNA-MEG3 could regulate the expression of KLF4 by adsorbing miR-543 and then plays a role in inhibiting the occurrence and development of NPC. It may be a new biomarker for NPC targeted therapy.

OBJECTIVE To explore the effect and mechanism of Kangaoheji(KAHJ)in the treatment of acute lung injury(ALI)in mice,and provide a rationale for its possible use as a drug to alleviate symptoms following coronavirus disease 2019(COV-ID-19)infection.METHODS Network pharmacology was carried out to predict the main active components and potential targets of KAHJ on ALI.C57BL/6J mice were randomly divided into Control group,LPS group and LPS+KAHJ group.LPS+KAHJ group was gavaged with KAHJ(4.76 g·kg-1·d-1,8.8 mL·kg-1·d-1)and the rest of the groups were gavaged with saline(8.8 mL·kg-1·d-1).LPS(5 mg·kg-1)was injected intraperitoneally to induce an acute inflammation model after 14 d.The ser-um and lung tissues of mice were collected,and the pathological changes in lung tissues were observed via histopathology.Western blot,Real-time PCR,Enzyme-Linked immunosorbent assay(ELISA)and immunohistochemistry(IHC)were used to assess the a-meliorative effect of KAHJ on ALI.RESULTS The result showed that 70 core target genes of KAHJ on ALI were primarily implicated in multiple signaling pathways involving MAPK signaling pathway,NF-κB signaling pathway,apoptosis,and Ras signaling pathway.Furthermore,we found that KAHJ ameliorated inflammation and apoptosis in ALI,thereby reducing lung damage and pulmo-nary edema and inhibiting pulmonary fibrosis.Additionally,KAHJ inhibited the phosphorylation of p38 MAPK and NF-κB,and up-regulated the ACE2/Ang1-7/Mas axis.CONCLUSION KAHJ might relieve acute lung injury through p38 MAPK/NF-κB signaling pathway and ACE2/Ang1-7/Mas axis,which offers complementary and alternative treatment options for COVID-19.

Objective:To investigate the characteristics of enterovirus (EV) VP1 gene from cases with hand, foot and mouth disease (HFMD) in Songjiang district of Shanghai in 2019.Methods:Samples from suspected HFMD cases were detected using real-time fluorescence reverse transcription polymerase chain reaction (RT-PCR). Human rhabdomyosarcoma (RD) cells were used for EV culture. VP1 genes of the isolated EV A species were sequenced. The sequences of nucleotide and amino acid of EV A species were used in phylogenetic and homology analysis by MEGA X software.Results:Totally 207 HFMD specimens were detected in 2019, of which 188 specimens were screened positive for EV. The positive rates of Coxsackievirus (CV)-A6, CV-A16, CV-A10 and CV-A4 were 47.34% (89/188), 41.49% (78/188), 3.72% (7/188) and 2.66% (5/188), respectively. Other EV species were 4.79% (9/188) positive and EV-A71 was not detected. During the summer epidemic peak of HFMD (May to July), B1 gene subtype of CV-A16 was detected more frequently, of which B1a and B1b evolutionary branches were prevalent together. The CV-A6 virus of D3a branch dominated in secondary peak of autumn and winter (September to December). CV-A10 and CV-A4 were sporadic and both respective strains belonged to subtypes of C2 gene. Compared with the prototype strains, the nucleotide (amino acid) sequence homologies of CV-A6, CV-A16, CV-A10 and CV-A4 VP1 genes were 79.22%-81.78% (95.97%~-97.19%), 62.70%-65.54% (90.10%-91.30%), 81.76%-82.65% (91.63% -92.03%) and 81.09%-81.79% (97.27%-97.67%), respectively.Conclusions:The diversity and complexity of HFMD pathogen epidemic increase the difficulty of HFMD prevention and control. The expansion of EV surveillance programs and the studies on the molecular epidemiology of EV are helpful for the prevention and control of HFMD.

OBJECTIVE: To evaluate the effect of rosmarinic acid (RA) on mitophagy and hypertrophy of cardiomyocytes exposed to high glucose (HG). METHODS: Rat cardiomyocytes (H9c2) exposed to HG (25 mmol/L) were treated with 50 μmol/L RA or with both RA treatment and Parkin siRNA transfection, with the cells cultured in normal glucose (5.5 mmol/L) and HG as the controls. The expressions of PINK1, Parkin and LC3II/LC3I in the cells were detected by Western blotting. The formation of mitochondrial autophagosomes was observed by transmission electron microscope. Flow cytometry was employed to detect the level of reactive oxygen species (ROS) and apoptotic rate of the cells. The activities of respiratory chain complex enzymes were measured by spectrophotometry. Fluorescence enzyme labeling and RESULTS: RA treatment significantly increased the expression levels of PINK1, Parkin and LC3-II/I ( CONCLUSIONS RA can protect rat cardiomyocytes against oxidative stress injury and cardiomyocyte hypertrophy induced by HG by activating Parkin-mediated mitophagy.
Animals ; Cinnamates ; Depsides ; Glucose ; Hypertrophy ; Mitophagy ; Myocytes, Cardiac ; Protein Kinases ; Rats ; Reactive Oxygen Species ; Ubiquitin-Protein Ligases/genetics*